Screen to Intervene: A Family-Centered Approach to Identifying and Communicating Family Psychosocial Risk and Developing Evidence Based Clinical Pathways in Hematopoietic Stem Cell Transplantation |
Alfred I duPont Hospital for Children / Anne Kazak, PhD |
Psychosocial Grants |
2015 |
Delaware |
Screening for New Rhabdomyosaroma Pathogenesis Genes in a Drosophila Model |
University of Texas Southwestern Medical Center / Kathleen Galindo |
Young Investigator Grants |
2012 |
Texas |
Searching for genetic vulnerabilities in osteosarcoma through genome-wide RNAi screening |
Dana-Farber Cancer Institute / Stuart Orkin, MD |
Innovation Grants |
2012 |
Massachusetts |
Selective Epigenetic Regulation of Notch1 in T-cell Acute Lymphoblastic Leukemia |
University of Michigan / Mark Yat-Fung Chiang, MD/PhD |
Innovation Grants |
2016 |
Michigan |
Selective inhibition of nuclear export as a novel therapeutic strategy in AML |
Dana-Farber Cancer Institute / Julia Etchin |
Young Investigator Grants |
2012 |
Massachusetts |
Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy |
Dana-Farber Cancer Institute / Jun Qi, PhD |
Innovation Grants |
2019 |
Massachusetts |
Self-Management of Cancer-Related Fatigue by Adolescents: Pilot Study of an Evidence Based Educational Resource.
|
Seattle Children’s Hospital and Regional Medical Center / Catherine Fiona Macpherson |
Nurse Researcher Grants |
2008 |
Washington |
Sepsis as innate immune stimulus: severe sepsis exposures and protection against relapse in children with acute leukemias |
Children’s Hospital of Philadelphia / Alix Seif, MD |
Epidemiology Grants |
2016 |
Pennsylvania |
Serious Morbidity and Financial Outcomes Among Pediatric Cancer Survivors |
Fred Hutchinson Cancer Research Center / Beth Mueller, PhD |
Epidemiology Grants |
2014 |
Washington |
SETD2 Mutations in Prognosis and Chemotherapy Resistance in Relapsed Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Brenton Mar, MD, PhD |
Young Investigator Grants |
2014 |
Massachusetts |